Sue-Hwa Lin Selected Research

Osteolysis

1/2020

Cabozantinib Reverses Renal Cell Carcinoma-mediated Osteoblast Inhibition in Three-dimensional Coculture In Vitro and Reduces Bone Osteolysis In Vivo.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Sue-Hwa Lin Research Topics

Disease

60	Prostatic Neoplasms (Prostate Cancer) 12/2023 - 08/2002
52	Neoplasms (Cancer) 12/2023 - 03/2002
40	Neoplasm Metastasis (Metastasis) 12/2023 - 05/2002
9	Carcinogenesis 01/2020 - 04/2004
6	Carcinoma (Carcinomatosis) 01/2020 - 05/2002
4	Renal Cell Carcinoma (Grawitz Tumor) 01/2020 - 08/2006
4	Breast Neoplasms (Breast Cancer) 01/2017 - 05/2004
3	Disease Progression 11/2023 - 01/2015
2	Germ Cell and Embryonal Neoplasms (Germ Cell Tumor) 10/2018 - 12/2016
2	Lymphatic Metastasis 04/2013 - 01/2007
2	Ovarian Neoplasms (Ovarian Cancer) 08/2010 - 06/2010
1	Pain (Aches) 05/2023
1	Myositis Ossificans (Fibrodysplasia Ossificans Progressiva) 01/2022
1	Heterotopic Ossification (Ectopic Ossification) 01/2022
1	Diarrhea 01/2020
1	Hypertension (High Blood Pressure) 01/2020
1	Osteolysis 01/2020
1	Seminoma 01/2018

Drug/Important Bio-Agent (IBA)

19	Proteins (Proteins, Gene)FDA Link 10/2021 - 07/2002
16	AndrogensIBA 12/2023 - 05/2002
8	Androgen Receptors (Androgen Receptor)IBA 12/2023 - 03/2002
8	osteoblast cadherinIBA 12/2015 - 08/2008
6	cabozantinibIBA 01/2020 - 11/2015
6	Biomarkers (Surrogate Marker)IBA 01/2020 - 02/2012
6	CEACAM1 ProteinIBA 11/2006 - 03/2002
5	Hormones (Hormone)IBA 12/2023 - 08/2003
5	Protein Isoforms (Isoforms)IBA 01/2022 - 06/2004
5	Conditioned Culture MediaIBA 01/2018 - 09/2002
4	Cell Adhesion MoleculesIBA 12/2015 - 09/2002
3	DNA (Deoxyribonucleic Acid)IBA 12/2023 - 08/2010
3	Bone Morphogenetic Protein 4IBA 05/2023 - 01/2021
3	Docetaxel (Taxotere)FDA Link 01/2023 - 03/2008
3	Radium-223IBA 01/2021 - 12/2018
3	Cadherins (E-Cadherin)IBA 03/2015 - 11/2013
3	Small Interfering RNA (siRNA)IBA 08/2010 - 09/2005
3	RadiopharmaceuticalsIBA 05/2010 - 11/2005
2	SteroidsIBA 12/2023 - 09/2005
2	Glucocorticoid Receptors (Glucocorticoid Receptor)IBA 11/2023 - 01/2020
2	Radioisotopes (Radionuclides)IBA 01/2021 - 05/2010
2	CytokinesIBA 01/2020 - 11/2006
2	Steroid Receptors (Steroid Receptor)IBA 01/2020 - 09/2005
2	Phosphotransferases (Kinase)IBA 01/2018 - 07/2015
2	Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA 09/2017 - 11/2015
2	Estrogen ReceptorsIBA 01/2017 - 01/2008
2	Estrogens (Estrogen)FDA Link 01/2017 - 01/2008
2	IntegrinsIBA 11/2015 - 04/2013
2	LigandsIBA 03/2015 - 12/2014
2	LuciferasesIBA 01/2013 - 09/2002
2	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 01/2012 - 07/2007
2	Forkhead Transcription Factors (Forkhead Box Proteins)IBA 07/2010 - 01/2008
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 06/2008 - 09/2002
2	Thalidomide (Thalomid)FDA Link 03/2008 - 08/2006
2	Transcription Factors (Transcription Factor)IBA 01/2008 - 05/2004
2	ProlactinIBA 01/2007 - 01/2003
2	Zoledronic Acid (Zometa)FDA Link 08/2006 - 08/2003
2	Bromodeoxyuridine (BrdU)IBA 09/2005 - 03/2002
1	Dehydroepiandrosterone (DHEA)IBA 12/2023
1	Androstenedione (4 Androstene 3,17 dione)IBA 12/2023
1	Testosterone (Sustanon)FDA Link 12/2023
1	Hydrocortisone (Cortisol)FDA LinkGeneric 12/2023
1	RNA (Ribonucleic Acid)IBA 12/2023
1	IsotopesIBA 12/2023
1	enzalutamideIBA 11/2023
1	Alendronate (Alendronate Sodium)FDA LinkGeneric 05/2023
1	CY5.5 cyanine dyeIBA 05/2023
1	Coloring Agents (Dyes)IBA 05/2023
1	cabazitaxel FDA Link 01/2023
1	taxaneIBA 01/2023
1	TenascinIBA 01/2022
1	PalovaroteneIBA 01/2022
1	Tretinoin (Retinoic Acid)FDA LinkGeneric 01/2022
1	Retinoic Acid Receptors (Retinoic Acid Receptor)IBA 01/2022
1	Proline (L-Proline)FDA Link 10/2021
1	Alanine (L-Alanine)FDA Link 10/2021
1	CateninsIBA 04/2021
1	MopidamolIBA 01/2021
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2021
1	LumicanIBA 01/2020
1	GlucocorticoidsIBA 01/2020
1	HydrogelsIBA 01/2020
1	E-SelectinIBA 01/2019
1	FucosyltransferasesIBA 01/2019
1	Cisplatin (Platino)FDA LinkGeneric 10/2018
1	GlypicansIBA 10/2018
1	Calmodulin (Calcium-Dependent Activator Protein)IBA 01/2018
1	CalciumIBA 01/2018
1	Phosphoric Monoester Hydrolases (Phosphatases)IBA 01/2018
1	human ERBB2 proteinIBA 01/2018
1	Calcium-Calmodulin-Dependent Protein Kinase Type 2IBA 01/2018
1	Phosphatidylinositols (Phosphatidylinositol)IBA 01/2018
1	Calcium-Calmodulin-Dependent Protein KinasesIBA 01/2018
1	TensinsIBA 01/2018
1	Acetyl Coenzyme A (Acetyl-CoA)IBA 01/2018

Therapy/Procedure

33	Therapeutics 12/2023 - 05/2002
8	Castration 01/2023 - 07/2007
5	Drug Therapy (Chemotherapy) 01/2021 - 11/2005
2	Immunotherapy 12/2023 - 09/2017
2	Prostatectomy (Retropubic Prostatectomy) 12/2019 - 01/2018
1	Adrenalectomy 12/2023
1	Drug Tapering 01/2020